Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression.
Chen Y, Zhang Q, Wang Q, Li J, Sipeky C, Xia J, Gao P, Hu Y, Zhang H, Yang X, Chen H, Jiang Y, Yang Y, Yao Z, Chen Y, Gao Y, Tan A, Liao M, Schleutker J, Xu J, Sun Y, Wei GH, Mo Z.
Chen Y, et al. Among authors: yao z.
Sci Rep. 2017 Jul 3;7(1):4538. doi: 10.1038/s41598-017-04731-4.
Sci Rep. 2017.
PMID: 28674394
Free PMC article.